Flebogamma DIF 5%, illustration of injection vial form (not a photo of the actual pack)

Illustrative image.

Flebogamma DIF 5%

Immune Globulin Intravenous (human Normal Immunoglobulin, Igg)

Prescription required

$732.00

0.05 · 5 vial · 6 months supply

BrandBranded medicine· By Grifols

$122.00 per month

How long a supply?

6 months$122.00 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$1464a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

0.05

FDA boxed warningThrombosis, renal dysfunction and acute renal failure

Thrombosis may occur with immune globulin intravenous (IGIV) products, including YIMMUGO

Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with the administration of IGIV products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. YIMMUGO does not contain sucrose

For patients at risk of thrombosis, renal dysfunction or renal failure, administer YIMMUGO at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity

Read this with the rest of the clinical information

Safety information

FDA boxed warning

Thrombosis, renal dysfunction and acute renal failure

Thrombosis may occur with immune globulin intravenous (IGIV) products, including YIMMUGO

Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with the administration of IGIV products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. YIMMUGO does not contain sucrose

For patients at risk of thrombosis, renal dysfunction or renal failure, administer YIMMUGO at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity

A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.

Using Flebogamma DIF 5%

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store in the original carton below 25°C, protected from light, unless the pack states refrigeration. Do not freeze. Keep all medicines out of the sight and reach of children.

Detailed information for this medicine is being written by our pharmacy team. Pack sizes and pricing are shown alongside.

Clinical information on this page is summarised from the US FDA label YIMMUGO (IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA) SOLUTION [KEDRION BIOPHARMA INC] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines